The Certified Methadone Advocate Course

Saturday, October 16, 2004 Preconference Events

Frederick W. Christie, MA

AFIRM

Long Island, New York
H. Westley Clark, MD, JD, MPH

CSAT

Rockville, MD
Stewart Leavitt, PHD

Addiction Treatment Forum

Glenview, IL
James P. Connolly, CMA

PA NAMA

Newtown, PA
Herman Joseph, PHD, CMA

NAMA

New York, NY
J. Thomas Payte, MD, CMA

Colonial Management Group

Orlando, FL
Walter Ginter, CMA

NAMA

Westport, CT
Thomas Kresina

NIDA/CSAT

Rockville, MD
Joycelyn Woods, MA, CMA

NAMA

New York, NY

It is the view of the National Alliance of Methafdone Advocates (NAMA) that everyone who supports the use of methadone treatment is a potential methadone advocate. We encourage all supporters of methadone treatment, patients and non-patient, to become Certified Methadone Advocates (CMAs) so that all the energies directed toward the advancement of methadone tratment produce positive results.

This course fulfills the training requirement for Certification as a Methadone Advocate. It is designed for non-clinicians and involves 8 hours of rigorius training. The course equips participants with the tools they will nedd to succeed in the strugle to have methadone maintenance treatment universally acceptied as the “gold standard” for addiction treatment.

With these goals in mind the course presetation is as follows:

  • Addiction and Methadone – scientifically accurate yet in language understandable to the non-clinician.
  • Regulation and Accreditation – explained by experts from the Center for Substance Abuse Treatment (CSAT) who understand the systemic complexities.
  • Methadone Mythology – exposing the myths surrounding methadone treatment.
  • The Certified Methadone Advocate (CMA) – the mechanism of certification and how it will professionalize those committed to advocacy, includes advocacy on the Net and Methadone Anonymous.
  • Methadone Stigma – a history of administrative and community prejudice directed at methadone patients, plus analyses of possible solutions.
  • Office-Based Treatment Model – whether buprenorphrine or methadone, an advance for patients and an administrative hurdle for implementation.
  • Hepatitis C – the second most important subject for all methadone patients.

Sponsored by the National Alliance of Methadone Advocates.

Supported by the National Institute on Drug Abuse, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment and Mallinckrodt, Inc.

Similar Posts

  • Myths About Methadone by Emmett Velten

    Admin 06/11/2022

    Methadose Dispensing Emmett Velten, Ph.D. is the Clinical Supervisor at the BAART Methadone Program, San Francisco, CA. Methadone has inspired an immense mythology.  Perhaps it is the most extensive mythology surrounding any form of medical or psychological treatment, living or dead. Why has such a mythology developed? This question is important given the deadly stakes…

  • Focus On

    Admin 02/26/2023

    Issues To Focus On Massachusetts Restores Methadone Funding Highlights from a compromise budget plan unveiled by House and Senate leaders on Thursday The $22.3 billion plan would: Restore Medicaid funding for 36,000 people under MassHealth Basic; Preserve a popular prescription drug coverage program for the elderly; Repeal the voter-approved Clean Elections law; Tighten the Quinn…

  • Lindesmith Center Seminar Schedule

    Admin 08/05/2022

    The Lindesmith Center’s SPECIAL DRUG POLICY SEMINAR SERIES Summer and Fall 1996 DRUG TREATMENT RECONSIDERED: HARM REDUCTION PERSPECTIVES The Lindesmith Center is presenting a special seminar series on the relationship between drug treatment and harm reduction. Harm reduction services focus on reducing the negative consequences of drug use among those unwilling or unable to abstain….

  • Blind Dosing

    Admin 05/05/2023

    Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…

  • Richard Lane/Robert Holden Methadone Advocacy Award

    Admin 09/12/2022

    Richard Lane was a long-term heroin user who, upon release from prison in 1967 helped to start Man Alive, one of the Nation’s first methadone treatment programs. In 1974, he became Executive Director of the program and later served as Vice President of the American Methadone Treatment Association. He served on several committees and was…

  • National Alliance of Methadone Advocates

    Admin 03/13/2023

    Membership Application Please complete and send to: National Alliance of Methadone Advocates 435 Second Avenue New York, NY, 10010 Name: Mr / Ms _______________________________________________________________________ Organization: _____________________________________ Title: ______________________________ Address: ____________________________________________________________________________ City: ___________________________________________________ State: ______________________ Zip Code (Postal Code): ____________________ Country: ____________________________________ Telephone: ______________________________________ Circle One: Day Eve Telephone: ______________________________________ Circle One: Day Eve Fax: ________________________________…